glp 1 with crohn's disease Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potential Glucagon-like peptide-1 (GLP-1) receptor agonists

WHO GLP-1 Treatments: The World Health Organization has issued new guidelines endorsing GLP-1 agonists as essential treatments for obesity, highlighting the urgent need for action against the rising global obesity epidemic affecting over one billion people and posing serious health risks.

Adults with obesity and autoimmune disease taking GLP-1 medication experience fewer cardiac events and have a lower risk of death, according to new findings.

Learn what to expect from compounded GLP-1 injections here.

This supplement is intended for women seeking natural support for their hormonal health during transitional periods.

The second developed approach, body roundness index (BRI), associates a persons shape phenotype with high-risk adiposity components and multiple health outcomes

While GLP-1 weight loss peptides such as semaglutide and tirzepatide have become buzzworthy for th...